Literature DB >> 9199556

Characterization of FMR1 promoter elements by in vivo-footprinting analysis.

S Schwemmle1, E de Graaff, H Deissler, D Gläser, D Wöhrle, I Kennerknecht, W Just, B A Oostra, W Döerfler, W Vogel, P Steinbach, W Dörfler.   

Abstract

Fragile X syndrome is associated with silencing of the FMR1 gene. We studied the transcriptional regulation, by analysis of the FMR1 promoter region for the presence of in vivo protein/DNA interactions and for cytosine methylation at the single-nucleotide level. Four protein-binding sites were present in the unmethylated promoter of the active FMR1 gene. In the methylated promoter of inactive genes no footprints were detected, and no evidence of active repression was found in the region investigated. We propose that the silencing of FMR1 gene transcription results from a lack of transcription-factor binding.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199556      PMCID: PMC1716109          DOI: 10.1086/515456

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  Genomic sequencing and methylation analysis by ligation mediated PCR.

Authors:  G P Pfeifer; S D Steigerwald; P R Mueller; B Wold; A D Riggs
Journal:  Science       Date:  1989-11-10       Impact factor: 47.728

2.  Identification and characterization of a novel transcription factor participating in the expression of eukaryotic initiation factor 2 alpha.

Authors:  W F Jacob; T A Silverman; R B Cohen; B Safer
Journal:  J Biol Chem       Date:  1989-12-05       Impact factor: 5.157

3.  Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated.

Authors:  M Höller; G Westin; J Jiricny; W Schaffner
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

Review 4.  Enhancers and transcription factors in the control of gene expression.

Authors:  B Wasylyk
Journal:  Biochim Biophys Acta       Date:  1988-11-10

5.  Cytosine methylation does not affect binding of transcription factor Sp1.

Authors:  M A Harrington; P A Jones; M Imagawa; M Karin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

6.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

7.  Normal phenotype in two brothers with a full FMR1 mutation.

Authors:  H J Smeets; A P Smits; C E Verheij; J P Theelen; R Willemsen; I van de Burgt; A T Hoogeveen; J C Oosterwijk; B A Oostra
Journal:  Hum Mol Genet       Date:  1995-11       Impact factor: 6.150

8.  Methylation analysis of CGG sites in the CpG island of the human FMR1 gene.

Authors:  R S Hansen; S M Gartler; C R Scott; S H Chen; C D Laird
Journal:  Hum Mol Genet       Date:  1992-11       Impact factor: 6.150

9.  High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome.

Authors:  I K Hornstra; D L Nelson; S T Warren; T P Yang
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

10.  Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor.

Authors:  E de Graaff; R Willemsen; N Zhong; C E de Die-Smulders; W T Brown; G Freling; B Oostra
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

View more
  14 in total

1.  A distinct DNA-methylation boundary in the 5'- upstream sequence of the FMR1 promoter binds nuclear proteins and is lost in fragile X syndrome.

Authors:  Anja Naumann; Norbert Hochstein; Stefanie Weber; Ellen Fanning; Walter Doerfler
Journal:  Am J Hum Genet       Date:  2009-10-22       Impact factor: 11.025

2.  The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat.

Authors:  P Steinbach; D Gläser; W Vogel; M Wolf; S Schwemmle
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

3.  Demethylation, reactivation, and destabilization of human fragile X full-mutation alleles in mouse embryocarcinoma cells.

Authors:  D Wöhrle; U Salat; H Hameister; W Vogel; P Steinbach
Journal:  Am J Hum Genet       Date:  2001-07-13       Impact factor: 11.025

4.  Hypomethylation of an expanded FMR1 allele is not associated with a global DNA methylation defect.

Authors:  R W Burman; P A Yates; L D Green; P B Jacky; M S Turker; B W Popovich
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

5.  Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations?

Authors:  U Salat; B Bardoni; D Wöhrle; P Steinbach
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

6.  Clinical utility gene card for: fragile X mental retardation syndrome, fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian insufficiency.

Authors:  Sebastien Jacquemont; Stefanie Birnbaum; Silke Redler; Peter Steinbach; Valérie Biancalana
Journal:  Eur J Hum Genet       Date:  2011-05-04       Impact factor: 4.246

7.  Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.

Authors:  Roberta Pietrobono; Maria Grazia Pomponi; Elisabetta Tabolacci; Ben Oostra; Pietro Chiurazzi; Giovanni Neri
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

8.  The roles of Sp1, Sp3, USF1/USF2 and NRF-1 in the regulation and three-dimensional structure of the Fragile X mental retardation gene promoter.

Authors:  Daman Kumari; Andrei Gabrielian; David Wheeler; Karen Usdin
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

Review 9.  Human pluripotent stem cell models of Fragile X syndrome.

Authors:  Anita Bhattacharyya; Xinyu Zhao
Journal:  Mol Cell Neurosci       Date:  2015-11-27       Impact factor: 4.314

10.  Age- and sex-dependent differential interaction of nuclear trans-acting factors with Fmr-1 promoter in mice brain.

Authors:  S Prasad; Kanchan Singh
Journal:  Neurochem Res       Date:  2007-12-14       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.